Founded in 2013, BioAscent is a leading provider of integrated drug discovery services based at the former Organon / MSD R&D site in Newhouse, Scotland.
Our drug discovery services include de novo assay development, target analysis and bespoke screening strategies, compound screening, medicinal and synthetic chemistry, computational chemistry and compound management, all with access to a library of 125K lead-like compounds and fragments library.
Our team of expert scientists has experience of successfully working from assay development through to preclinical and clinical candidates across all biological target classes and major therapeutic indications. As part of its compound management service, BioAscent currently holds and manages over 1 million compounds for our customers, in both liquid and solid formats.
Site |
Badges |
|
Bioascent
Bo'Ness Road
, Scotland,
United Kingdom
|
|
|
Bioascent
Bo’Ness Road
Newhouse, Lanarkshire, , ML1 5UH
United Kingdom
|
|